Helsinki is one of the most liveable cities in the world, where everything just works – with no hiccups.
These 7 facts about Helsinki make the city a hiccup-free hub for the life sciences.
The most advanced testbed in the world
Finland boasts a wide range of national biobanks, health data registries, large sample research results and piloting opportunities available for commercial R&D. Over 98% of patients have given permission for their samples to be stored in biobanks. By combining extended medical records with a state-of-the-art research infrastructure, Helsinki is currently building an innovation platform which will take personalised health to a whole new level.
Seamless cooperation between public and private sectors
Partnerships with public agencies, such as the Hospital District of Helsinki and Uusimaa (HUS) and Helsinki University Central Hospital (HUCH), enable companies to reach into the research ecosystem. The HUS is the 2nd largest hospital in western Europe and its testbed service portfolio covers primary care, dental care, and specialised care, medical research and education, engineering, and business know-how.
The testbeds in hospitals are open to companies for testing healthtech or digital health products in well-supervised environments with real patients. Across all public and private sector partnerships, stringent compliance with EU data protection legislation is enforced.
Finland has the most digital health startups per capita in the world. This development has deep roots in medical technology – Finland has been a ‘small giant’ in medical equipment, sports wearables and heart rate monitoring for decades, and is now pioneering new innovations in wireless solutions, software, games and 5G technologies. In Finland, eHealth and eSocial solutions are used to ensure that people living in sparsely populated areas will also have equal access to services. Health technology is Finland’s number one high technology export field, with a total value of €2.11 billion in 2016.
What are you interested in?
The most crucial criterion for transferring the European Medicines Agency (EMA) to its new location is the ability to affect a smooth transition with no hiccups.
Placing EMA alongside the European Chemicals Agency (ECHA) in Helsinki enhances the EU’s global regulatory competitiveness.
Finland and the Helsinki region possess top class expertise in the life sciences in terms of a high-quality talent pool, world-leading research, strong support services, and functioning networks of collaboration among academia, industry and the public sector.
Helsinki is a famously liveable city with no hiccups. This makes it a perfect home for the EMA.
Helsinki is one of the most liveable cities in the world, where everything just works with no hiccups.
Supporting the application of the Republic of Finland for the relocation of the European Medicines Agency to Helsinki.
Helsinki Business Hub